Patent · US Active

Use of gingival fibroblasts in the treatment of alopecia

US10624838B2 · kind B2 · utility

3Cited by

1References

6Claims

0Family size

Assignees

ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
Institut de Radioprotection et de Surete Nucleaire · FR
ETAT FRANCAIS—MINISTERE DE LA DEFENSE—DIRECTION CENTRALE DU SERVICE DE SANTE DES ARMEES · FR
UNIVERSITE DE PARIS DESCARTES · FR

Inventors

Antoine Lafont · Paris, FR
Bernard Coulomb · Igny, FR
Jean-Jacques Lataillade · Élancourt, FR
Christine LINARD · Ris-Orangis, FR

Key dates

Filing date	Jul 9, 2014
Grant date	Apr 21, 2020
Priority date	—
Expiry date	Jul 9, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2800/40
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of gingival fibroblast-derived products to reduce hair loss and promote hair growth. Specifically, the invention relates to a product derived from gingival fibroblasts to be used in the treatment or prevention of alopecia, as well as in the promotion of natural hair growth and/or in the control of natural hair loss.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.